Frozen copy retrieved 2026-08-20T20:14:00Z for audit 2026-08-20T21-09-12Z. Original URL: https://www.foxnews.com/video/6403756363112. The Stochastic Parrot does not host or redistribute; this snapshot exists solely so that quoted spans remain verifiable if the original page changes. Character offsets below index into this plain text; highlighted spans are the quotes cited in the audit.

Vaccine targeting skin cancer shows promising results

Fox News (video segment, Fox & Friends First — the ONLY current-story coverage found in the right bucket) · back to the audit

Video page, no transcript available. On-page description (verbatim, og:description): "Amen Clinics Associate Medical Director Dr. Eboni Cornish joins 'Fox & Friends First' to discuss a groundbreaking new mRNA melanoma vaccine from Merck and Moderna that reduced the risk of recurrence or death by 49% after five years."

On-page body text (verbatim): "A groundbreaking clinical trial reveals a new mRNA melanoma vaccine developed by Merck and Moderna reduces recurrence or death rates by 49 percent over five years. Dr. Eboni Cornish, Associate Medical Director of Amen Clinics, explains how this personalized immunotherapy uses artificial intelligence to target specific tumor mutations. This medical breakthrough represents the future of cancer treatment."

AUDIT NOTE (load-bearing): The 49% figure in the on-page description corresponds to the EARLIER mid-stage (Phase 2b/January) dataset, NOT a new hazard ratio from the Phase 3 interim release. No Phase 3 hazard ratio has been released by anyone in this corpus. Fox News's only current-story engagement with the Aug 19/20, 2026 story is this video segment. NO written right-bucket coverage of the Phase 3 story was found across the full roster (NY Post, Washington Examiner, Washington Times, Fox Business, Newsmax, Breitbart, Townhall, National Review, Daily Wire, Daily Signal all searched/fetched within budget).